Christy Forehand Pharm.D., Russel Roberts Pharm.D., Nicole M. Acquisto Pharm.D., FCCP, Mitchell Buckley Pharm.D., FCCP, Christine M. Groth Pharm.D., Devin Holden Pharm.D., Andrea Sikora Pharm.D., Thomas (Tomi) Ardiles M.D., Melissa Thompson Bastin Pharm.D., Ph.D., Sivasubramanium V. Bhavani M.D., Ashley DePriest M.S., Ifeoma Mary Eche Pharm.D., Brigid Flynn M.D., William J. Healy M.D., Brett Hogan MSN, Brenton LaRiccia M.S., MBA, Kirby Mayer DPT, Ph.D., David Murphy M.D., Ph.D., Lucy Stun Pharm.D., Shan Wang Pharm.D., Nicola Zetola M.D., Robert MacLaren Pharm.D., MPH, FCCP
{"title":"EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA-PHARMS): The clinical pharmacist's perspective","authors":"Christy Forehand Pharm.D., Russel Roberts Pharm.D., Nicole M. Acquisto Pharm.D., FCCP, Mitchell Buckley Pharm.D., FCCP, Christine M. Groth Pharm.D., Devin Holden Pharm.D., Andrea Sikora Pharm.D., Thomas (Tomi) Ardiles M.D., Melissa Thompson Bastin Pharm.D., Ph.D., Sivasubramanium V. Bhavani M.D., Ashley DePriest M.S., Ifeoma Mary Eche Pharm.D., Brigid Flynn M.D., William J. Healy M.D., Brett Hogan MSN, Brenton LaRiccia M.S., MBA, Kirby Mayer DPT, Ph.D., David Murphy M.D., Ph.D., Lucy Stun Pharm.D., Shan Wang Pharm.D., Nicola Zetola M.D., Robert MacLaren Pharm.D., MPH, FCCP","doi":"10.1002/jac5.2040","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.</p>\n </section>\n \n <section>\n \n <h3> Design, Setting, and Participants</h3>\n \n <p>An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.</p>\n </section>\n \n <section>\n \n <h3> Main Outcomes and Measures</h3>\n \n <p>The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.</p>\n </section>\n </div>","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":"7 11","pages":"1084-1093"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Clinical Pharmacy : JACCP","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jac5.2040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Critical care pharmacists are well-established, valuable members of the intensive care unit interprofessional team with unique skills to perform comprehensive medication management in complex critically ill patients. However, standardized and consequential productivity metrics for critical care pharmacists have not been established.
Objective
To characterize the utilization and perception of contemporary critical care pharmacy productivity metrics utilized among individual institutions.
Design, Setting, and Participants
An electronic survey was distributed to critical care pharmacist members of the Society of Critical Care Medicine Clinical Pharmacy and Pharmacology Section and the American College of Clinical Pharmacy Critical Care Practice and Research Network.
Main Outcomes and Measures
The survey included 23 questions to assess institution demographics, individual respondent demographics, institution practices, and individual respondent perceptions about the value of critical care pharmacist productivity metrics.
Results
A total of 204 critical care pharmacists, largely from the United States, responded to the survey between July and November 2022. Institutional metrics captured by more than 50% of the respondents' institutions included order verification rate/number of orders verified (60%), number of clinical interventions (57%), and intravenous to enteral product interchanges (52%). Of these metrics, critical care pharmacists only agreed with the value of the number of clinical interventions, were indifferent to the value of intravenous to oral product interchanges, and disagreed with the value of order verification rate/number of orders verified.
Conclusions
Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists.